Domenico Sergi

1.9k total citations
54 papers, 796 citations indexed

About

Domenico Sergi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Domenico Sergi has authored 54 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 15 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Domenico Sergi's work include Cancer Treatment and Pharmacology (17 papers), Breast Cancer Treatment Studies (13 papers) and Colorectal Cancer Treatments and Studies (8 papers). Domenico Sergi is often cited by papers focused on Cancer Treatment and Pharmacology (17 papers), Breast Cancer Treatment Studies (13 papers) and Colorectal Cancer Treatments and Studies (8 papers). Domenico Sergi collaborates with scholars based in Italy, Malaysia and United States. Domenico Sergi's co-authors include Patrizia Vici, Laura Pizzuti, Maddalena Barba, Luigi Di Lauro, Marcello Maugeri‐Saccà, Enrico Vizza, Marcella Mottolese, Ruggero De Maria, Teresa Gamucci and Clara Natoli and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Domenico Sergi

53 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Domenico Sergi Italy 16 359 178 166 157 106 54 796
Georgia A. McCann United States 16 554 1.5× 250 1.4× 150 0.9× 135 0.9× 98 0.9× 37 897
Ida Paris Italy 16 370 1.0× 210 1.2× 189 1.1× 167 1.1× 206 1.9× 72 870
Laure Favier France 16 573 1.6× 328 1.8× 197 1.2× 172 1.1× 78 0.7× 61 1.0k
Sophie Barrett United Kingdom 9 295 0.8× 256 1.4× 54 0.3× 161 1.0× 68 0.6× 18 660
Heike Engel United States 15 345 1.0× 211 1.2× 73 0.4× 92 0.6× 58 0.5× 25 1.3k
Paweł Mach Germany 16 186 0.5× 127 0.7× 81 0.5× 168 1.1× 53 0.5× 59 646
Darlene Gibbon United States 15 325 0.9× 375 2.1× 115 0.7× 109 0.7× 65 0.6× 38 834
Şennur İlvan Türkiye 19 212 0.6× 131 0.7× 153 0.9× 128 0.8× 206 1.9× 78 1.1k
Joanne Jeter United States 14 349 1.0× 154 0.9× 106 0.6× 117 0.7× 42 0.4× 37 675

Countries citing papers authored by Domenico Sergi

Since Specialization
Citations

This map shows the geographic impact of Domenico Sergi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Domenico Sergi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Domenico Sergi more than expected).

Fields of papers citing papers by Domenico Sergi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Domenico Sergi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Domenico Sergi. The network helps show where Domenico Sergi may publish in the future.

Co-authorship network of co-authors of Domenico Sergi

This figure shows the co-authorship network connecting the top 25 collaborators of Domenico Sergi. A scholar is included among the top collaborators of Domenico Sergi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Domenico Sergi. Domenico Sergi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Anwar, Ayesha Saeed, Domenico Sergi, et al.. (2025). Emerging Links Between Ferroptosis and Neurodegeneration: Implications for Disease Mechanisms and Nutraceutical Interventions. Food Science & Nutrition. 13(6). e70385–e70385. 1 indexed citations
2.
Chiofalo, Benito, Giuseppe Sanguineti, Laura Pizzuti, et al.. (2024). Breast and cervical cancer in transgender men: literature review and a case report. Therapeutic Advances in Medical Oncology. 16. 12704202–12704202. 2 indexed citations
3.
Sergi, Domenico, Natalie D. Luscombe‐Marsh, Nenad Naumovski, Mahinda Y. Abeywardena, & Nathan J. O’Callaghan. (2023). Long-chain saturated fatty acids at the interface between mitochondrial dysfunction and OxInflammation: implications for metabolic health. Free Radical Biology and Medicine. 198. S3–S3. 1 indexed citations
4.
5.
Barchiesi, Giacomo, Marco Mazzotta, Eriseld Krasniqi, et al.. (2020). Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives. International Journal of Molecular Sciences. 21(10). 3528–3528. 50 indexed citations
6.
Krasniqi, Eriseld, Giacomo Barchiesi, Laura Pizzuti, et al.. (2019). Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives. Journal of Hematology & Oncology. 12(1). 111–111. 96 indexed citations
7.
Moscetti, Luca, Lucia Mentuccia, Patrizia Vici, et al.. (2017). ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study. Future Oncology. 13(17). 1517–1525. 4 indexed citations
8.
Ercolani, Cristiana, Anna Di Benedetto, Irene Terrenato, et al.. (2017). Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy. Cancer Biology & Therapy. 18(5). 339–346. 15 indexed citations
9.
Barba, Maddalena, Patrizia Vici, Laura Pizzuti, et al.. (2017). Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer. BMC Cancer. 17(1). 101–101. 7 indexed citations
10.
Lauro, Luigi Di, Laura Pizzuti, Maddalena Barba, et al.. (2015). Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study. Journal of Experimental & Clinical Cancer Research. 34(1). 26–26. 15 indexed citations
11.
Vici, Patrizia, Marcella Mottolese, Laura Pizzuti, et al.. (2014). The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy. Oncotarget. 5(20). 9619–9625. 31 indexed citations
12.
Vici, Patrizia, Anna Crispo, Antonio Giordano, et al.. (2014). Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer. Journal of Cellular Physiology. 230(8). 1708–1712. 1 indexed citations
13.
Vici, Patrizia, Luciano Mariani, Laura Pizzuti, et al.. (2014). Emerging Biological Treatments for Uterine Cervical Carcinoma. Journal of Cancer. 5(2). 86–97. 40 indexed citations
14.
Vici, Patrizia, Laura Pizzuti, Teresa Gamucci, et al.. (2014). Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of Cancer. 5(6). 398–405. 6 indexed citations
15.
Vici, Patrizia, Luciano Mariani, Laura Pizzuti, et al.. (2014). Immunologic treatments for precancerous lesions and uterine cervical cancer. Journal of Experimental & Clinical Cancer Research. 33(1). 29–29. 32 indexed citations
16.
Pizzuti, Laura, Domenico Sergi, Maddalena Barba, & Patrizia Vici. (2013). Unusual long-lasting cutaneous complete response to lapatinib and capecitabine in a heavily pretreated HER2-positive plurimetastatic breast cancer patient.. PubMed. 99(3). e127–30. 3 indexed citations
17.
Vici, Patrizia, Domenico Sergi, Laura Pizzuti, et al.. (2011). [Specificity of action of anticancer agents].. PubMed. 162(2). 137–49. 1 indexed citations
18.
López, Manuela G., Luigi Di Lauro, Paolo Foggi, et al.. (2009). [Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer].. PubMed. 160(6). 481–8. 2 indexed citations
19.
Vici, Patrizia, Silvia Rossi, Claudio Botti, et al.. (2009). Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.. PubMed. 159(6). 453–6. 7 indexed citations
20.
Vici, Patrizia, Luigi Di Lauro, Domenico Sergi, et al.. (2008). A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines. Oncology. 75(3-4). 175–181. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgia A. McCann Breakdown of academic impact, for papers by Ida Paris Breakdown of academic impact, for papers by Laure Favier Breakdown of academic impact, for papers by Sophie Barrett Breakdown of academic impact, for papers by Heike Engel Breakdown of academic impact, for papers by Paweł Mach Breakdown of academic impact, for papers by Darlene Gibbon Breakdown of academic impact, for papers by Şennur İlvan Breakdown of academic impact, for papers by Joanne Jeter
Rankless by CCL
2026